CLDN18.2 resources

Explore additional resources to learn more about how to consistently test, interpret, and report CLDN18.2 in G/GEJ cancer.

Global RING Trial

Review the Global RING Study which determined the reproducibility and comparability of CLDN18 testing in gastric cancer.

Explore our expert-recommended IHC Implementation Guide to help you set up a new biomarker assay in your lab.

Access a self-guided CLDN18.2 educational program.

Explore the results of two phase 3 clinical trials focused on the analytical and clinical performance of the VENTANA CLDN18 (43-14A) RxDx Assay.

By signing up, you will receive updates about testing for CLDN18.2. You

may also be contacted by an Astellas representative.

*Required fields

By signing up, you will receive updates about testing for CLDN18.2. You

may also be contacted by an Astellas representative.

*Required fields

Please complete required fields.

You must agree to the Terms of Use and Privacy Policy.

First Name

Please enter First Name.

Last Name

Please enter Last Name.

Profession Type

Please select Profession Type.

State

Please select State.

Phone Number

Please enter 10-digit Phone Number.

Email Address

Please enter a valid Email Address.

You must agree to the Terms of Use and Privacy Policy.